Investing.com — The landscape of GLP-1 drugs, which are widely recognized for their efficacy in weight loss and diabetes management, is poised
Investing.com — The U.S. housing market is expected to see mild improvements in 2025, but elevated mortgage rates and affordability challenges will continue
TOKYO (Reuters) – Honda (NYSE:HMC) and Nissan (OTC:NSANY) are considering producing vehicles in one another’s factories as part of their
By Jody Godoy (Reuters) – Alphabet (NASDAQ:GOOGL)’s Google proposed on Friday a loosening of its agreements with Apple (NASDAQ:AAPL) and others to set
TORONTO (Reuters) – A U.S. judge ruled on Friday in favor of Meta (NASDAQ:META) Platform Inc’s WhatsApp in a lawsuit accusing Israel’s
By Bhanvi Satija (Reuters) -The U.S. Food and Drug Administration on Friday approved Eli Lilly (NYSE:LLY)’s weight-loss treatment, Zepbound, for obstructive sleep apnea,
By David Shepardson WASHINGTON (Reuters) -The U.S. Commerce Department said on Friday it was finalizing an award of up to $4.745 billion to
By David Shepardson WASHINGTON (Reuters) -The top Democrat on the House of Representatives Appropriations Committee said on Friday that Republicans in Congress were
Investing.com — Qualcomm scored a major legal victory on Friday when a U.S. jury determined that the company didn’t violate its licensing
By David Shepardson WASHINGTON (Reuters) – A partial government shutdown could cost the U.S. travel industry $1 billion per week and lead to
